Study: Low Birth Defect Risk From Newer Epilepsy Drugs

Study: Low Birth Defect Risk From Newer Epilepsy Drugs Researchers Say Findings Are Reassuring, but Data on Topamax Inconclusive WebMD Medical News By Salynn Boyles Reviewed by Laura J. Martin,...

Click here to read the full story.

Post a Comment
 

 
Comments
No comments yet!
Inergize Digital This site is hosted and managed by Inergize Digital.
   

WTVQ.com supports children's privacy rights. All persons under the age of 13 MUST have parental permission to use this website and direct parental supervision is strongly recommended.